Search Results - "Cannon, M V"

In silico assessment of primers for eDNA studies using PrimerTree and application to characterize the biodiversity surrounding the Cuyahoga River by Cannon, M. V., Hester, J., Shalkhauser, A., Chan, E. R., Logue, K., Small, S. T., Serre, D.

“…Analysis of environmental DNA (eDNA) enables the detection of species of interest from water and soil samples, typically using species-specific PCR. Here, we…”
Get full text

Mitochondrial DNA Sequence and Phylogenetic Evaluation of Geographically Disparate Sus scrofa Breeds by Cannon, M. V., Brandebourg, T. D., Kohn, M. C., Đikić, D., Irwin, M. H., Pinkert, C. A.

“…Next generation sequencing of mitochondrial DNA (mtDNA) facilitates studies into the metabolic characteristics of production animals and their relation to…”
Get full text

Xenomitochondrial mice: investigation into mitochondrial compensatory mechanisms by Cannon, M V, Dunn, D A, Irwin, M H, Brooks, A I, Bartol, F F, Trounce, I A, Pinkert, C A

“…Xenomitochondrial mice, harboring evolutionarily divergent Mus terricolor mitochondrial DNA (mtDNA) on a Mus musculus domesticus nuclear background…”
Get full text

Repair of traumatic skeletal muscle injury with bone-marrow-derived mesenchymal stem cells seeded on extracellular matrix by Merritt, Edward K, Cannon, Megan V, Hammers, David W, Le, Long N, Gokhale, Rohit, Sarathy, Apurva, Song, Tae J, Tierney, Matthew T, Suggs, Laura J, Walters, Thomas J, Farrar, Roger P

“…Skeletal muscle injury resulting in tissue loss poses unique challenges for surgical repair. Despite the regenerative potential of skeletal muscle, if a…”
Get more information

Cardiac-specific overexpression of LXR-alpha attenuates left ventricular hypertrophy by modulating glucose uptake and metabolism by Cannon, M. V., Sillje, H. H. W., Segbers, M., Van Der Sluis, B., Van Deursen, J. M., Vreeswijk-Baudoin, I., Silva, G. J. J., De Windt, L. J., Van Gilst, W. H., De Boer, R. A.

Get full text

LXRα improves myocardial glucose tolerance and reduces cardiac hypertrophy in a mouse model of obesity-induced type 2 diabetes by Cannon, Megan V., Silljé, Herman H. W., Sijbesma, Jürgen W. A., Khan, Mohsin A. F., Steffensen, Knut R., van Gilst, Wiek H., de Boer, Rudolf A.

“…Aims/hypothesis Diabetic cardiomyopathy is a myocardial disease triggered by impaired insulin signalling, increased fatty acid uptake and diminished glucose…”
Get full text

Cardiac LXRα protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization by Cannon, Megan V, Silljé, Herman HW, Sijbesma, Jürgen WA, Vreeswijk‐Baudoin, Inge, Ciapaite, Jolita, van der Sluis, Bart, van Deursen, Jan, Silva, Gustavo JJ, de Windt, Leon J, Gustafsson, Jan‐Åke, van der Harst, Pim, van Gilst, Wiek H, de Boer, Rudolf A

“…Pathological cardiac hypertrophy is characterized by a shift in metabolic substrate utilization from fatty acids to glucose, but the molecular events…”
Get full text

Mouse cardiac LXRalpha overexpression as a model to modulate cardiac metabolism and trigger specific fetal gene expression to ameliorate pathological hypertrophy by De Boer, RAR, Cannon, MV, Sijbesma, JWA, Vreeswijk-Baudoin, I, De Windt, LJ, Khan, MAF, Steffensen, KR, Sillje, HH, Van Gilst, WH

Get full text